The purpose of this study is to research more reasonable and safe methods of nutritional support to improve the nutritional status of tumor patients, which guarantees the anti-tumor treatment such as chemotherapy.
This study is a prospective, randomized, controlled clinical trials. 300 patients were randomly divided into 2 groups for its own control study. Test group: Zhen qishen capsule (2 capsules, Bid) and Oral Supplement of Yuyikang (50g,Bid), a total of 150 people, are used for 42 days continuously. Placebo group: Zhen qishen capsule placebo (2 capsules, Bid) and Oral Supplement of Yuyikang placebo (50g, Bid), a total of 150 people, are used for 42 days continuously. The subjects were randomized to AB or BA parallely, and the two groups were given chemotherapy and nutrition.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
300
National Cancer Institute, Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
RECRUITINGWeight change rate
Time frame: 6 weeks and 9 weeks after baseline.
Siderophilin change status
Time frame: 6 weeks and 9 weeks after baseline.
Interleukin 1 change status
Time frame: 6 weeks and 9 weeks after baseline.
interleukin 6 change status
Time frame: 6 weeks and 9 weeks after baseline.
Tumor Necrosis Factor α change status
Time frame: 6 weeks and 9 weeks after baseline.
Change status of the Gripping Power
Time frame: 6 weeks and 9 weeks after baseline.
Prealbumin Blood Examination change status
Time frame: 6 weeks and 9 weeks after baseline.
Albumin change status
Time frame: 6 weeks and 9 weeks after baseline.
Total Bilirubin change status
Time frame: 6 weeks and 9 weeks after baseline.
Bilirubin Direct change status
Time frame: 6 weeks and 9 weeks after baseline.
Indirect Bilirubin change status
Time frame: 6 weeks and 9 weeks after baseline.
Alkaline Phosphatase change status
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: 6 weeks and 9 weeks after baseline.
Alanine Aminotransferase change status
Time frame: 6 weeks and 9 weeks after baseline.
Aspartate Aminotransferase change status
Time frame: 6 weeks and 9 weeks after baseline.
Serum Creatinine change status
Time frame: 6 weeks and 9 weeks after baseline.
Urine Nitrogen change status
Time frame: 6 weeks and 9 weeks after baseline.
Lymphocyte Number change status
Time frame: 6 weeks and 9 weeks after baseline.
Hemoglobin change status
Time frame: 6 weeks and 9 weeks after baseline.